Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding. The investor was TIO Bioventures.
Source: Press Release
Treadwell Therapeutics scores $27 mln seed
Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
